1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. SYNCOM FORMULATION (INDIA) LTD.
Syncom Formulation (India) Ltd. BSE: 524470 | ASM

Syncom Formulation (India) Ltd. Live Share Price Today, Share Analysis and Chart

Mid-range Performer
about

Syncom Formulations (India) is engaged in manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups...

Read More
18.68 -0.65 (-3.36%)
33.14% Fall from 52W High
2.2M
NSE+BSE Volume

BSE 19 Jun, 2025 4:01 PM (IST)

Watchlist

Portfolio

Alert

Share
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
High Financial Strength
80.0 / 100
Valuation Score
Mid Valuation
40.0 / 100
Momentum Score
Technically Neutral
47.5 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
No estimates available

24

S

5

W

3

O

0

T

SWOT Analysis

Syncom Formulation (India) Ltd. Live Price Chart



Loading Fundamental data..


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

All Earnings Calls
Annual Report Mar-2024
pdf
Annual Report Mar-2023
pdf
Annual Report Mar-2022
pdf
Annual Report Mar-2021
pdf
Annual Report Mar-2020
pdf
Annual Report Mar-2019
pdf
Annual Report Mar-2018
pdf
Annual Report Mar-2017
pdf
Annual Report Mar-2016
pdf
Annual Report Mar-2015
pdf
Annual Report Mar-2014
pdf
Annual Report Mar-2013
pdf
Annual Report Mar-2012
pdf

Syncom Formulation (India) Ltd. FAQ

How is Syncom Formulation (India) Ltd. today?
Syncom Formulation (India) Ltd. today is trading in the red, and is down by -3.36% at 18.68.
Syncom Formulation (India) Ltd. is currently trading down -3.36% on an intraday basis. In the past week the stock fell -15.74%. stock has been up 19.44% in the past quarter and rose 48.25% in the past year. You can view this in the overview section.